# Disseminated Rothia kristinae Infection: A Case Highlighting an Emerging Pathogen

**Authors:** Kody Dormire, Sravani Kamatam, Moni Roy, Sharjeel Ahmad

PMC · DOI: 10.1155/carm/4049568 · 2026-01-29

## TL;DR

This paper presents a case of widespread Rothia kristinae infection, highlighting its potential to cause severe disease and the need for early treatment.

## Contribution

The paper contributes a detailed clinical case highlighting Rothia kristinae as an emerging pathogen with disseminated infection potential.

## Key findings

- Rothia kristinae caused native aortic valve endocarditis, discitis, and septic arthritis in a 70-year-old woman.
- The infection required prolonged antibiotic treatment and surgical intervention.
- The case underscores the pathogenic potential of Rothia kristinae and the importance of early clinical suspicion.

## Abstract

Rothia kristinae is usually found in the environment, on normal skin and mucosal surfaces of humans, and there is a limited medical literature available on this organism and its pathogenicity. Our case describes a woman in her early 70’s with left hip osteoarthritis presented with generalized weakness, fever, and altered mentation associated with left hip and back pain. Laboratory workup was significant for leukocytosis and elevated inflammatory markers. Blood culture demonstrated Gram‐positive cocci, later identified as Rothia kristinae. She was subsequently diagnosed with native aortic valve endocarditis, multilevel discitis, and left hip septic arthritis. She completed 2 weeks of intravenous vancomycin. Treatment was complicated by a drug reaction to vancomycin and switched to linezolid. She developed a left hip abscess and underwent left hip arthroplasty. Follow‐up transthoracic echocardiogram showed resolution of infective endocarditis. This case describes the extent of disseminated infection the organism can cause and its pathogenic potential warranting a low threshold for clinicians to initiate treatment.

## Linked entities

- **Chemicals:** vancomycin (PubChem CID 14969), linezolid (PubChem CID 3929)
- **Diseases:** osteoarthritis (MONDO:0005178), endocarditis (MONDO:0005025), septic arthritis (MONDO:0004471)

## Full-text entities

- **Diseases:** discitis (MESH:D015299), infection (MESH:D007239), leukocytosis (MESH:D007964), hip osteoarthritis (MESH:D015207), aortic valve endocarditis (MESH:D001024), fever (MESH:D005334), inflammatory (MESH:D007249), infective endocarditis (MESH:D004696), hip and back pain (MESH:D001416), hip abscess (MESH:D000038), hip septic arthritis (MESH:D001170), weakness (MESH:D018908)
- **Chemicals:** linezolid (MESH:D000069349), vancomycin (MESH:D014640)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rothia kristinae (species) [taxon 37923]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12855622/full.md

---
Source: https://tomesphere.com/paper/PMC12855622